{"pmid":32355564,"pmcid":"PMC7192073","title":"Consideration of dornase alfa for the treatment of severe COVID-19 ARDS.","text":["Consideration of dornase alfa for the treatment of severe COVID-19 ARDS.","New Microbes New Infect","Earhart, Alexander P","Holliday, Zachary M","Hofmann, Hunter V","Schrum, Adam G","32355564"],"journal":"New Microbes New Infect","authors":["Earhart, Alexander P","Holliday, Zachary M","Hofmann, Hunter V","Schrum, Adam G"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32355564","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.nmni.2020.100689","topics":["Treatment"],"weight":1,"_version_":1666138495167496193,"score":9.490897,"similar":[{"pmid":32483527,"pmcid":"PMC7242210","title":"Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a.","text":["Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a.","The outbreak of the new coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Until now, no definite effective treatment has been identified. We reported 3 patients with severe COVID-19 treated with pegylated interferon alfa 2a with satisfactory recovery. Based on these observations, randomized studies with interferons should be considered in deteriorating patients infected with COVID-19.","IDCases","El-Lababidi, Rania M","Mooty, Mohamad","Bonilla, Maria-Fernanda","Salem, Nouran M","32483527"],"abstract":["The outbreak of the new coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Until now, no definite effective treatment has been identified. We reported 3 patients with severe COVID-19 treated with pegylated interferon alfa 2a with satisfactory recovery. Based on these observations, randomized studies with interferons should be considered in deteriorating patients infected with COVID-19."],"journal":"IDCases","authors":["El-Lababidi, Rania M","Mooty, Mohamad","Bonilla, Maria-Fernanda","Salem, Nouran M"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32483527","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.idcr.2020.e00837","keywords":["coronavirus disease 2019","interferons","pegylated interferon alfa 2a","sars-cov-2"],"topics":["Case Report"],"weight":1,"_version_":1668704334393638912,"score":44.91712}]}